Determination of biomarker candidates for the placenta accreta spectrum by plasma proteomic analysis

Abstract excerpt

Placenta accreta spectrum (PAS) presents a significant obstetric challenge, associated with considerable maternal and fetal-neonatal morbidity and mortality. Nevertheless, it is imperative to acknowledge that a noteworthy subset of PAS cases remains undetected until the time of delivery, thereby contributing to an augmented incidence of morbidity among the affected individuals. The delayed identification of PAS...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Maternal and fetal healthcare
• Share to Neonatal Respiratory Health Research
• Share to Pregnancy and preeclampsia studies